For the third year in a row, Carver Bank, the largest Black-owned financial institution, brought prostate cancer screenings.

A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of prostate cancer progression to help identify its clinical outcomes.

TUESDAY, Feb. 18, 2025 (HealthDay News) -- A mobile "Man Van" screening program detected dozens of prostate cancer cases in ...

Testosterone therapy after prostate cancer surgery does not appear to increase biochemical recurrence (BCR) risk in patients with low-risk disease, investigators report.

Prostate cancer has become England's most common cancer as more men are getting checked. Prostate Cancer UK analysis shows diagnoses of the disease overtook breast cancer in 2022 and 2023.

Researchers at Vanderbilt and the University of Michigan have shown that a simple at-home urine test for prostate cancerscreeningis highly accurate. The exciting new results, published in The Journal ...

Barry Goy, MD, provides insight into the clinical implications of a retrospective analysis examining 15-year outcomes in patients with intermediate-risk prostate cancer.

Currently, the US is the major market for prognostic cancer tests, estimated to be worth in excess of $1billion for prostate cancer. OncoAssure now plans to launch the OncoAssure Prostate test in ...

Small, MD, deputy director and chief scientific officer of the UCSF Helen Diller Family Comprehensive Cancer Center and co-director of the UCSF Prostate Cancer Program with Feng. “But as important as ...

PORTOS can determine which patients with localized prostate cancer will benefit from dose-escalation of radiotherapy, data suggest.